¹Adams D, et al., "Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients."Journal of Pediatric Hematology-Oncology 1996; 18 (1): 46–50.

²Danielson C, et al., "The role of Red Blood Cell Exchange transfusion in the treatment and prevention of complications of sickle cell disease."Therapeutic Apheresis 2002; 6 (1): 24-31.

³Wahl S, et al., "Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions."Transfusion 2012; 52 (12): 2671–2676.

⁴Lawson SE, et al., "Red cell exchange in sickle cell disease."Clinical & Laboratory Haemotology 1999; 21 (2): 99–102.

⁵Wayne S, et al., "Transfusion management of sickle cell disease."Blood 1993; 81 (5): 1109-1123.

⁶Cabibbo S, et al., "Chronic RBC exchange to prevent clinical complications in sickle cell disease."Transfusion Apheresis Science 2005; 32 (3): 315-321.

⁷Hilliard L, et al., "Erythrocytapheresis limits iron accumulation in chronically transfused SCD patients."American Journal of Hematology 1998; 59 (1): 28-35.

⁸Duclos C, et al., "Long-term red blood cell exchange in children with sickle cell disease: Manual or automatic?"Transfusion Apheresis Science 2013; 48 (2): 219-222.

⁹Singer S, et al., "Erythrocytapheresis for chronically transfused children with sickle cell disease: An effective method for maintaining a low HbS level and reducing iron overload."Journal of Clinical Apheresis 1999; 14 (3): 122-125.